B hücreli lenfomalar, lenf nodlarında ortaya çıkan non-Hodgkin lenfomaların büyük çoğunluğunu oluşturmalarına karşın, primer kutanöz lenfomaların az bir kısmını oluşturur. Primer kutanöz lenfomalar farklı klinik görünüm, histopatoloji, immünfenotip özellikler gösteren heterojen bir grup hastalıktır. Primer kutanöz B hücreli lenfomalar, tüm kutanöz lenfomaların %20-25'ini oluşturmaktadır. 'Primer kutanöz difüz büyük B hücreli lenfoma, diğer tip' oldukça nadir görülen bir kutanöz lenfoma olup, literatürde sınırlı sayıda olgu bildirilmiştir. Tanı kriterlerinin olmaması ve sınıflandırma kriterlerinin karışık/belirsiz olması nedeniyle hastalar yanlış veya geç tanı alabilmektedirler. Bu olgu sunumunda, primer kutanöz B hücreli lenfomaların oldukça nadir görülen bu tipini ayırıcı tanıda akla gelmesini vurgulamak amacıyla sunmak istedik.
Anahtar Kelimeler: B hücreli lenfoma; difüz büyük B hücreli lenfoma; deri neoplazmları
B-cell lymphoma is the most common non-Hodgkin's lymphoma which arise in lymph nodes, but on the other hand, it comprises only a small fraction of primary cutaneous lymphomas. Primary cutaneous lymphomas are a heterogeneous group of diseases with different clinical features, histopathology and immunophenotypes. Primary cutaneous lymphomas represent 20-25% of all cutaneous lymhomas. "Primary cutaneous diffuse large B cell lymphoma, other type" is a very rare primary cutaneous lymphoma and so far, only a limited number of cases have been reported in the literature. Patients might be misdiagnosed or diagnosed late because of the vague classification criteria of the disease and/or the absence of diagnostic criteria. We would like to present this case with this rare subtype of primary cutaneous B-cell lymphoma in order to emphasize that this disease should be considered in the differential diagnosis.
Keywords: B cell lymphoma; diffuse large B cell lymphoma; skin neoplasms
- Willemze R. Thirty years of progress in cutaneous lymphoma research. G Ital Dermatol Venereol. 2012;147(6):515-21.
- Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2018;93(11):1427-30. [Crossref] [PubMed]
- Senff NJ, Noordijk EM, Kim YH, Bagot M, Berti E, Cerroni L, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112(5):1600-9. [Crossref] [PubMed]
- Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-85. [Crossref] [PubMed]
- Cerroni L. B-cell lymphomas of the skin. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018. p.2113-26.
- Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20): 2375-90. [Crossref] [PubMed] [PMC]
- Sokol L, Naghashpour M, Glass LF. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Cancer Control. 2012;19(3):236-44. [Crossref] [PubMed]
- Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood. 2007;109(2):478-85. [Crossref] [PubMed]
- Cerroni L. Skin Lymphoma-The Illustrated Guide. 4th ed. Oxford: Wiley-Blackwell; 2014. p.438. [Crossref]
- Senff NJ, Zoutman WH, Vermeer MH, Assaf C, Berti E, Cerroni L, et al. Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol. 2009;129(5):1149-55. [Crossref] [PubMed]
- Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol. 2007;25(12):1581-7. [Crossref] [PubMed]
- Suarez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. J Am Acad Dermatol. 2013;69(3):329.e1-13. [Crossref] [PubMed]
- Graham PM, Richardson AS, Schapiro BL, Saunders MD, Stewart DM. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response. JAAD Case Rep. 2018;4(4):305-9. [Crossref] [PubMed] [PMC]
- Kempf W, Kazakov DV, Mitteldorf C. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions. Am J Dermatopathol. 2014;36(3):197-208. [Crossref] [PubMed]
- Jia J, Li W, Zheng Y. Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: a case report and review of literature. Medicine (Baltimore). 2017;96(8):e6161. [Crossref] [PubMed] [PMC]
- Geelen FA, Vermeer MH, Meijer CJ, Van der Putte SC, Kerkhof E, Kluin PM, et al. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol. 1998;16(6):2080-5. [Crossref] [PubMed]
- Paulli M, Lucioni M, Maffi A, Croci GA, Nicola M, Berti E. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment. G Ital Dermatol Venereol. 2012;147(6):589-602.
- Petkovic IZ, Pejcic I, Tiodorovic D, Krstic M, Stojnev S, Vrbic S. Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type. Postepy Dermatol Alergol. 2017;34(6):625-8. [Crossref] [PubMed] [PMC]
- Plaza JA, Kacerovska D, Sangueza M, Schieke S, Buonaccorsi N, Suster S, et al. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases. Am J Dermatopathol. 2014;36(6):478-82. [Crossref] [PubMed]
.: Process List